Biotech · Private company
Minerva Biotechnologies Corporation
Track this companyFree. Adds Minerva Biotechnologies Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cellsPhase 1 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells @ RP2DPhase 1 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)PHASE1 · RECRUITING · started Jan 15, 2020ClinicalTrials.gov NCT04020575 · fetched Nov 12, 2026